COVID-19 Boost As Pharma ROI Hits Heights Not Seen For Seven Years, Finds Deloitte

Close-up Of White Increasing Staircase Arrow On Wooden Background
Forecasted Return On Investment Leapt To 7%, But It Is Unclear How Long The Pandemic's Effects Will Last • Source: Alamy

More from Business

More from Scrip